Vactosertib in Combination with Pembrolizumab in Metastatic Colorectal or Gastric Cancer

Clinical trial NCT03724851 · COMPLETED

Trial details

NCT number: NCT03724851
Sponsor: MedPacto, Inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Metastatic Colorectal Cancer Gastric Cancer Gastroesophageal Junction Adenocarcinoma

Start date: 2018-12-20
Primary completion: 2024-05-07
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.